StockDrifts LogoStockDrifts

BiotoxTech 086040

Company
바이오톡스텍BiotoxTech
Insiders
4
Buys
11
Total Value
₩196M ($136K)
Avg Return
+8.29%
Last Filing
2026-02-09

BiotoxTech (086040) has 11 disclosed insider purchases and 1 disclosed disposals on record, filed by 4 distinct insiders. Together those filings cover ₩196M ($136K) in reported transaction value. The earliest filing StockDrifts holds for BiotoxTech is dated 2024-03-29; the most recent is 2026-02-09. Across these filings the average return since disclosure is +8.29%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-09-23BUYMarket Buy
강종구
Kang Jong-gu
CEO1.8K₩2,245+0.0%₩4M ($3K)
2026-09-18BUYMarket Buy
강종구
Kang Jong-gu
CEO900₩2,305-2.6%₩2M ($1K)
2026-09-04BUYMarket Buy
강종구
Kang Jong-gu
CEO2.3K---
2026-09-03BUYMarket Buy
강종구
Kang Jong-gu
CEO3.8K---
2026-09-02BUYMarket Buy
강종구
Kang Jong-gu
CEO2.0K---
2026-09-01BUYMarket Buy
강종구
Kang Jong-gu
CEO2.6K₩2,500+0.0%₩7M ($5K)
2026-08-31BUYMarket Buy
강종구
Kang Jong-gu
CEO3.8K₩2,500+0.0%₩9M ($7K)
2026-08-28BUYMarket Buy
강종구
Kang Jong-gu
CEO3.9K₩2,500+0.0%₩10M ($7K)
2026-08-27BUYMarket Buy
강종구
Kang Jong-gu
CEO4.9K₩2,430+2.9%₩12M ($8K)
2026-08-26BUYMarket Buy
강종구
Kang Jong-gu
CEO5.1K₩2,485+0.6%₩12M ($8K)
2026-08-25BUYMarket Buy
강종구
Kang Jong-gu
CEO4.9K₩2,435+2.7%₩11M ($8K)
2026-08-24BUYMarket Buy
강종구
Kang Jong-gu
CEO3.9K₩2,380+5.0%₩9M ($6K)
2026-08-21BUYMarket Buy
강종구
Kang Jong-gu
CEO4.4K₩2,380+5.0%₩10M ($7K)
2026-08-06BUYMarket Buy
정수용
For water purification
vice president10.1K₩2,260-0.2%₩22M ($15K)
2026-07-29BUYMarket Buy
최주영
Jooyoung Choi
Managing Director212₩2,080+6.0%₩448K ($311)
2026-07-28BUYMarket Buy
최주영
Jooyoung Choi
Managing Director426₩2,135+3.3%₩889K ($618)
2026-07-27BUYMarket Buy
김지영
Jiyoung Kim
moving4.3K₩2,205-6.1%₩9M ($6K)
2026-07-23BUYMarket Buy
최주영
Jooyoung Choi
Managing Director100₩2,175+1.4%₩208K ($144)
2026-02-09BUYMarket Buy
정수용
For water purification
vice president19.8K₩2,590+25.3%₩51M ($36K)
2026-01-22BUYMarket Buy
최주영
Jooyoung Choi
Managing Director3.7K₩2,610+24.3%₩10M ($7K)
2026-01-21BUYMarket Buy
정수용
For water purification
vice president18.9K₩2,635+23.1%₩50M ($35K)
2026-01-15BUYMarket Buy
박선희
Seonhee Park
Managing Director7.3K₩2,670+21.5%₩19M ($13K)
2026-01-08BUYMarket Buy
김지영
Jiyoung Kim
moving3.8K₩2,700+20.2%₩10M ($7K)
2025-12-10BUYMarket Buy
정수용
For water purification
Managing Director18.7K₩2,645+22.7%₩49M ($34K)
2025-01-10BUYMarket Buy
박선희
Seonhee Park
Managing Director190₩3,340-2.8%₩635K ($441)
2025-01-10BUYMarket Buy
박선희
Seonhee Park
Managing Director40₩3,340-2.8%₩134K ($93)
2024-12-09BUYMarket Buy
박선희
Seonhee Park
Managing Director310₩3,000+8.2%₩930K ($646)
2024-08-12BUYMarket Buy
박선희
Seonhee Park
Managing Director160₩5,100-36.4%₩816K ($567)
2024-06-13SELLMarket Sell
박선희
Seonhee Park
Managing Director-450₩5,390+39.8%₩2M ($2K)
2024-05-08BUYMarket Buy
박선희
Seonhee Park
Managing Director200₩5,750-43.6%₩1M ($799)
2024-03-29BUY신규선임
박선희
Seonhee Park
Managing Director1.0K₩6,000-45.9%₩6M ($4K)
2024-03-29BUY신규선임
박선희
Seonhee Park
Managing Director2.0K₩6,000-45.9%₩12M ($8K)

Frequently asked questions

Who has been buying BiotoxTech stock?
4 distinct insiders have filed 11 disclosed insider purchases in BiotoxTech (086040), most recently on 2026-02-09. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does BiotoxTech have?
BiotoxTech has 11 buy-side and 1 sell-side disclosures on record, covering ₩196M ($136K) in total reported value, spanning 2024-03-29 to 2026-02-09.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.